Daniela Cilloni

Daniela Cilloni

UNVERIFIED PROFILE

Are you Daniela Cilloni?   Register this Author

Register author
Daniela Cilloni

Daniela Cilloni

Publications by authors named "Daniela Cilloni"

Are you Daniela Cilloni?   Register this Author

100Publications

2279Reads

34Profile Views

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients.

Neurol Ther 2020 Jun 16. Epub 2020 Jun 16.

SSD Terapia oncoematologica intensiva e trapianto CSE, AOU San Luigi Gonzaga, Dipartimento di Scienze Cliniche e Biologiche, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40120-020-00200-9DOI Listing
June 2020

Phenotypical heterogeneity of acute myeloid leukemia in the elderly: a clue for a personalized therapy?

Leuk Lymphoma 2020 May 13;61(5):1234-1237. Epub 2020 Jan 13.

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1709833DOI Listing
May 2020

Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe.

Int J Mol Sci 2020 May 30;21(11). Epub 2020 May 30.

Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21113928DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312164PMC
May 2020

Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes.

Ann Hematol 2020 Apr 4;99(4):891-893. Epub 2020 Feb 4.

Department of Clinical and Biological Sciences of the University of Turin, San Luigi Hospital, Regione Gonzole 10, 10043 ORBASSANO, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-03913-xDOI Listing
April 2020

Impact of kidney transplant morbidity on elderly recipients' outcomes.

Aging Clin Exp Res 2020 Apr 23. Epub 2020 Apr 23.

Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40520-020-01558-4DOI Listing
April 2020

Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.

J Clin Med 2020 Mar 16;9(3). Epub 2020 Mar 16.

Department of Clinical and Biological Sciences, University of Turin, 10124 Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9030802DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141302PMC
March 2020

Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literature.

Leuk Lymphoma 2020 01 10;61(1):234-236. Epub 2019 Sep 10.

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1660969DOI Listing
January 2020

Highly Sensitive Detection of Mutations in Acute Myeloid Leukemia.

J Clin Med 2020 Jan 19;9(1). Epub 2020 Jan 19.

Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, Regione Gonzole 10, 10043 Orbassano (Turin), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9010271DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019902PMC
January 2020

Two conserved glycine residues in mammalian and Rictor are required for mTORC2 activity and integrity.

J Cell Sci 2019 11 14;132(22). Epub 2019 Nov 14.

Department of Oncology, University of Torino, AOU S. Luigi, 10043 Orbassano (TO), Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.236505DOI Listing
November 2019

Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and Kusec.

Br J Haematol 2019 08 1;186(4):639-640. Epub 2019 May 1.

Department of Biomedicine and Prevention, Universita' Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15938DOI Listing
August 2019

Discrete Changes in Glucose Metabolism Define Aging.

Sci Rep 2019 07 17;9(1):10347. Epub 2019 Jul 17.

UOC Laboratorio Cellule Staminali post-natali e Terapie Cellulari, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-46749-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637183PMC
July 2019

Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?

Int J Mol Sci 2019 May 7;20(9). Epub 2019 May 7.

Department of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20092249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540058PMC
May 2019

Venetoclax plus decitabine induced complete remission with molecular response in acute myeloid leukemia relapsed after hematopoietic stem cell transplantation.

Am J Hematol 2019 02 29;94(2):E48-E50. Epub 2018 Nov 29.

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25352
Publisher Site
http://dx.doi.org/10.1002/ajh.25352DOI Listing
February 2019

Strategies for minimal residual disease detection: current perspectives.

Blood Lymphat Cancer 2019 12;9:1-8. Epub 2019 Feb 12.

Department of Clinical and Biological Sciences, University of Turin, Turin,Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S172693DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855617PMC
February 2019

Expressional changes in stemness markers post electrochemotherapy in pancreatic cancer cells.

Bioelectrochemistry 2018 Aug 15;122:84-92. Epub 2018 Mar 15.

Cork Cancer Research Centre, Western Gateway Building, University College Cork, Ireland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioelechem.2018.03.009DOI Listing
August 2018

Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia.

Leuk Res 2018 04 5;67:6-11. Epub 2018 Feb 5.

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.01.016DOI Listing
April 2018

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

Cell Oncol (Dordr) 2017 Oct 18;40(5):483-496. Epub 2017 Jul 18.

Laboratory of Pre-clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata (CROB), via Padre Pio, 1, 85028, Rionero in Vulture, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-017-0338-4DOI Listing
October 2017

Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes.

Br J Haematol 2017 02 23;176(3):491-495. Epub 2016 Feb 23.

Dipartimento di Scienze Cliniche e Biologiche, AOU San Luigi Gonzaga, Università di Torino, Orbassano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13968DOI Listing
February 2017

Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.

Am J Hematol 2016 09 4;91(9):918-22. Epub 2016 Jul 4.

Department of Experimental and Clinical Medicine and DENOTHE Excellence Center, CRIMM-Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24442DOI Listing
September 2016

New possibilities to exploit the potentiality of cord blood cells in the context of transplantation.

Immunol Lett 2013 Sep-Oct;155(1-2):24-6. Epub 2013 Sep 27.

Dipartimento di Emato-Oncologia e Laboratorio Cellule Staminali Post-Natali e Terapie Cellulari, Istituto Giannina Gaslini Gaslini, Genova, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2013.09.024DOI Listing
July 2014

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

J Clin Oncol 2014 Jan 2;32(3):219-28. Epub 2013 Dec 2.

Roelof Willemze, Constantijn J.M. Halkes, and Erik W.A. Marijt, Leiden University Medical Center, Leiden; Petra Muus, Joop Jansen, and Theo de Witte, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; Stefan Suciu and Liv Meert, European Organisation for Research and Treatment of Cancer Headquarters; Dominique Bron, Hôpital Universitaire, Bordet-Erasme, Brussels; Dominik L.D. Selleslag, Algemeen Ziekenhuis Sint-Jan, Brugge; Zwi Berneman, Universitair Ziekenhuis, Antwerpen; Georges Fillet, Centre Hospitalier Universitaire du Sart-Tilman, Liège; Anne Hagemeijer, Center for Human Genetics, University of Leuven, Leuven, Belgium; Giovanna Meloni, Marco Mancini, Silvia Maria Trisolini, and Franco Mandelli, "Sapienza" University; Sergio Amadori and Adriano Venditti, Tor Vergata University Hospital; Simona Sica, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli; Paola Fazi and Marco Vignetti, Gruppo Italiano Malattie Ematologiche dell' Adulto Foundation, Central Office, Rome; Giorgina Specchia, Università degli Studi di Bari, Bari; Francesco Fabbiano, Ospedali Riuniti "Villa Sofia-Cervello"; Maria Enza Mitra, Policlinico "Paolo Giaccone," Palermo; Francesco Nobile, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria; Marco Sborgia, Azienda Unitá Sanitaria Locale di Pescara, Pescara; Andrea Camera, L'A.O. Universitaria-Università degli Studi di Napoli "Federico II," Napoli; Domenico Magro, A.O. Pugliese Ciaccio, Catanzaro; Nicola Cantore, A.O. San Giuseppe Moscati, Avellino; Lorella Melillo, Istituto Di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza, San Giovanni Rotondo; Pietro Leoni, A.O. Nuovo Ospedale Torrette, Ancona; Mario Luppi, A.O. Universitaria di Modena, Modena; Daniela Cilloni, University of Torino, Torino, Italy; Boris Labar, University Hospital Center-Rebro, Zagreb, Croatia; Jean-Pierre Marie, Saint-Antoine Hospital, Assistance Publique-Hopitaux de Paris and University Paris 6; Francois Lef

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.8571DOI Listing
January 2014

Molecular pathways: BCR-ABL.

Clin Cancer Res 2012 Feb 8;18(4):930-7. Epub 2011 Dec 8.

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1613DOI Listing
February 2012

Iron chelation therapy in myelodysplastic syndromes.

Adv Hematol 2010 20;2010:756289. Epub 2010 Jun 20.

Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Regione Gonzole 10, 10043 Orbassano (To), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/756289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905902PMC
July 2011

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes.

Leuk Res 2011 Apr 23;35(4):504-7. Epub 2010 Oct 23.

Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Via Benevento 6, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.08.021DOI Listing
April 2011

Emerging targets for hematological malignancies.

Curr Opin Drug Discov Devel 2010 Sep;13(5):548-58

University of Turin, San Luigi Hospital, Department of Clinical and Biological Sciences, Gonzole 10, 10043 Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
September 2010

Emerging drugs for chronic myeloid leukemia.

Expert Opin Emerg Drugs 2010 Jun;15(2):175-84

University of Turin, Department of Clinical and Biological Sciences, S. Luigi Hospital, Regione Gonzole 10, 10043, Orbassano Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728211003621220DOI Listing
June 2010

HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.

Int J Hematol 2009 Oct 12;90(3):392-396. Epub 2009 Sep 12.

Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, Regione Gonzole 10, 10043, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-009-0418-yDOI Listing
October 2009

CML: a model for targeted therapy.

Best Pract Res Clin Haematol 2009 Sep;22(3):285-94

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2009.04.004DOI Listing
September 2009

Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases.

Pediatr Hematol Oncol 2009 Apr-May;26(3):129-35

Pediatric Hematology & Oncology, G. Di Cristina Children's Hospital, Palermo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08880010902773024DOI Listing
June 2009

New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia.

Expert Rev Hematol 2009 Jun;2(3):297-303

Department of Hematology/Oncology L and A Seràgnoli, S. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.09.16DOI Listing
June 2009

Imatinib resistance in CML.

Cancer Lett 2009 Feb 23;274(1):1-9. Epub 2008 Jul 23.

Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, San Luigi Hospital, 10043 Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2008.06.003DOI Listing
February 2009

Molecular monitoring in patients with chronic myelogenous leukemia.

Curr Hematol Malig Rep 2008 Apr;3(2):65-71

Department of Clinical and Biological Sciences of the University of Turin, San Luigi Hospital, Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-008-0011-0
Publisher Site
http://dx.doi.org/10.1007/s11899-008-0011-0DOI Listing
April 2008

New therapeutic approaches and prognostic factors in chronic myeloid leukemia.

Leuk Lymphoma 2008 Apr;49(4):625-8

Division of Haematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190801896210DOI Listing
April 2008

Nuclear factor kB as a target for new drug development in myeloid malignancies.

Haematologica 2007 Sep 1;92(9):1224-9. Epub 2007 Aug 1.

Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.11199DOI Listing
September 2007

Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.

Ann N Y Acad Sci 2006 Nov;1089:411-23

Department of Clinical and Biological Sciences of the University of Turin, San Luigi Hospital, Gonzole 10, 10043 Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1386.030DOI Listing
November 2006